General Announcement::NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Securities
CHINA MEDICAL SYSTEM HLDGS LTD - KYG211081248 - 8A8
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
22-Jun-2026 17:37:26
Status
New
Announcement Sub Title
NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China
Announcement Reference
SG260622OTHRPJ9Z
Submitted By (Co./ Ind. Name)
Wu Sanyan
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

CMS-NDA of Recombinant Fully Human Bispecific Antibody Against RABV Silevimig Approved in China.pdf
Total size =420K